Heterogeneous drug penetrance of veliparib and carboplatin measured in triple negative breast tumors.

Breast Cancer Res · 2017 · PMC5594551 · PMID 28893315

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

This study showed a trend but did not meet its significance cut off when evaluating progression-free survival benefit [ 53 ].

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.